Reporting parties
Subject security
Symbol
LXEO
Shares outstanding
74,300,257 shares
Ownership signal
SEC evidence
Form type
SCHEDULE 13G/A
Filing time
17 Feb 2026, 16:38:17 UTC
Event date
31 Dec 2025
Previous filing
14 Aug 2025
SEC filing
View on sec.gov

Key filing fact

CITADEL ADVISORS LLC disclosed 7.4% ownership in Lexeo Therapeutics, Inc. Common Stock ($0.0001 par value) (the "Shares") (LXEO) on 31 Dec 2025.

Key facts

  • CITADEL ADVISORS LLC filed SCHEDULE 13G/A for Lexeo Therapeutics, Inc. Common Stock ($0.0001 par value) (the "Shares") (LXEO).
  • Disclosed ownership: 7.4%.
  • Date of event: 31 Dec 2025.

Change

  • Previous schedule filing date: 14 Aug 2025.
  • Current filing was accepted on 17 Feb 2026, 16:38.

Research use

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting persons

Reporting managers (7)

Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Citadel Advisors LLC 7.2% 5,405,269 0 5,405,269 /s/ Seth Levy Seth Levy, Authorized Signatory
Citadel Advisors Holdings LP 7.2% 5,405,269 0 5,405,269 /s/ Seth Levy Seth Levy, Authorized Signatory
Citadel GP LLC 7.2% 5,405,269 0 5,405,269 /s/ Seth Levy Seth Levy, Authorized Signatory
Citadel Securities LLC 0% 6,600 0 6,600 /s/ Seth Levy Seth Levy, Authorized Signatory
Citadel Securities Group LP 0.1% 92,950 0 92,950 /s/ Seth Levy Seth Levy, Authorized Signatory
Citadel Securities GP LLC 0.1% 92,950 0 92,950 /s/ Seth Levy Seth Levy, Authorized Signatory
Kenneth Griffin 7.4% 5,498,219 0 5,498,219 /s/ Seth Levy Seth Levy, attorney-in-fact*
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .